Slootweg Hugo Alexander

Sociétés où Slootweg Hugo Alexander a négocié

• Replimune Group, Inc.15 tx · $2M · Apr 4, 2023

Historique de performance de Slootweg Hugo Alexander

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de Slootweg Hugo Alexander

Co-initiés de Slootweg Hugo Alexander

• Astley-Sparke PhilipForbion European Acquisition Corp. +1
• Bain Capital Life Sciences Investors, LLCNewAmsterdam Pharma Co N.V. +1
• BCIP Life Sciences Associates, LPNewAmsterdam Pharma Co N.V. +1
• Forbion Growth Management B.V.Forbion European Acquisition Corp. +1
• Forbion Growth Opportunities Fund I Cooperatief U.A.Forbion European Acquisition Corp. +1
• Joustra WouterForbion European Acquisition Corp. +1
• 667, L.P.Replimune Group, Inc.
• Atlas Venture Associates Opportunity I, LLCReplimune Group, Inc.
• Atlas Venture Associates Opportunity I, L.P.Replimune Group, Inc.
• Atlas Venture Associates X, LLCReplimune Group, Inc.
• ATLAS VENTURE ASSOCIATES X, L.P.Replimune Group, Inc.
• Atlas Venture Fund X, L.P.Replimune Group, Inc.
• Atlas Venture Opportunity Fund I, L.P.Replimune Group, Inc.
• Audet Juliette BerangereNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Fund III, L.P.NewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Fund II, L.P.NewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Fund, L.P.Replimune Group, Inc.
• Bain Capital Life Sciences III General Partner, LLCNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Investors II, LLCNewAmsterdam Pharma Co N.V.
• Bain Capital Life Sciences Partners, LPReplimune Group, Inc.
• Baker Bros. Advisors (GP) LLCReplimune Group, Inc.